CDH1 and lung carcinoma: Bone marrow-derived MSCs (BMSCs) can produce miR-126-3p to target and inhibit CCR1 expression, thereby inhibiting neural cadherin (N-cadherin, N-cad) and vimentin expression, promoting epithelial cadherin (E-cadherin, E-cad) expression, and ultimately inhibiting the proliferation, migration, and invasion of A549 lung cancer cells [74].